Latest

Learn how antibiotic-resistant UTI testing identifies ESBL, CRE, resistance genes, and antibiotic susceptibility, and how culture results guide treatment and follow-up.

Antibiotic-Resistant UTI Test: ESBL, CRE, Resistance Markers, and Culture Meaning

Learn what asymptomatic bacteriuria means, how a positive urine culture without UTI symptoms is interpreted, and when screening, treatment, or follow-up matters.

Asymptomatic Bacteriuria Test: Positive Culture Without Symptoms and When It Matters

Learn how bacteria in urine are interpreted using urinalysis, culture, colony count, symptoms, and sample quality, including when contamination or follow-up testing matters.

Bacteria in Urine Test: UTI, Contamination, Colony Count, and Culture Follow-Up

Learn how a catheter urine culture helps diagnose catheter-associated UTI, how samples are collected, and what colony counts, pyuria, resistance, and positive results mean.

Catheter Urine Culture Test: Catheter-Associated UTI and Culture Meaning

Learn how a chlamydia and gonorrhea urine NAAT works, how to collect first-catch urine, what positive or negative results mean, and when follow-up testing is needed.

Chlamydia and Gonorrhea Urine NAAT Test: STI Screening, Positive Result, and Meaning

Learn how to collect a clean-catch urine culture, reduce contamination, handle the sample correctly, and understand mixed flora, colony counts, repeat testing, and accurate results.

Clean-Catch Urine Culture Test: Sample Collection, Contamination, and Accurate Results

Diagnostics

Home Diagnostics Page 27

Understand DNMT3A mutation test results in AML and clonal hematopoiesis, including R882 variants, VAF, CHIP and CCUS, prognosis, remission persistence, and follow-up meaning.

DNMT3A Mutation Test: AML, Clonal Hematopoiesis, Myeloid Neoplasms, and Mutation Meaning

Learn how a double-hit lymphoma FISH panel interprets MYC, BCL2, and BCL6 rearrangements, including double-hit, triple-hit, double-expressor, and modern classification meaning.

Double-Hit Lymphoma FISH Panel: MYC, BCL2, BCL6, and Rearrangement Status

Understand FLT3 mutation test results in AML, including ITD vs TKD, ELN 2022 risk, allelic ratio, VAF, targeted therapy, MRD, relapse retesting, and prognosis.

FLT3 Mutation Test: AML Risk, Mutation Status, Prognosis, and Result Meaning

Learn how hematologic cancer biomarker panels use flow cytometry, IHC, FISH, PCR, NGS, and protein studies to diagnose and classify leukemia, lymphoma, and myeloma.

Hematologic Cancer Biomarker Panel: Leukemia, Lymphoma, Myeloma Markers, and Diagnosis

Understand what an IDH1 mutation test means in AML, including R132 variants, positive and negative results, VAF, prognosis, targeted IDH1 therapy, and follow-up.

IDH1 Mutation Test for AML: Mutation Status, Molecular Result, and AML...

Learn how to interpret an IDH2 mutation test in AML, including R140 and R172 results, VAF, prognosis, enasidenib treatment relevance, and follow-up testing.

IDH2 Mutation Test for AML: Mutation Status, Molecular Result, and AML...

Learn what a JAK2 exon 12 mutation test means in V617F-negative erythrocytosis, how it supports polycythemia vera diagnosis, and what to do after a negative result.

JAK2 Exon 12 Mutation Test: Polycythemia Vera Marker and JAK2-Negative Workup

Learn how to interpret a JAK2 V617F mutation test, including positive results, polycythemia vera and MPN meaning, VAF, negative follow-up, and prognosis.

JAK2 V617F Mutation Test: Myeloproliferative Neoplasm, Polycythemia Vera, and Positive Result

Learn what a high LDH test can mean in leukemia, lymphoma, and myeloma, including prognosis, disease activity, false elevations, reference ranges, and tumor lysis risk.

Lactate Dehydrogenase (LDH) Test for Blood Cancer: High Levels, Prognosis, and...

Understand leukemia flow cytometry panels, including CD markers, immunophenotype, blast assessment, AML and ALL patterns, test limits, and follow-up testing.

Leukemia Flow Cytometry Panel: Cell Markers, Immunophenotype, Blasts, and Diagnosis

Learn how lymphoma flow cytometry uses B-cell, T-cell, and NK-cell markers to detect clonality, classify abnormal populations, and guide confirmatory testing.

Lymphoma Flow Cytometry Panel: B-Cell, T-Cell, NK-Cell Markers, and Classification

Understand leukemia MRD testing with flow cytometry, PCR, and NGS, including sensitivity, positive and negative results, timing, relapse risk, and test limitations.

Minimal Residual Disease (MRD) Test for Leukemia: Flow Cytometry, PCR, NGS,...

Understand multiple myeloma MRD testing by flow cytometry and NGS, including 10⁻⁵ to 10⁻⁶ sensitivity, negative and positive results, recurrence risk, and limitations.

Minimal Residual Disease (MRD) Test for Myeloma: Flow Cytometry, NGS, and...

Understand MPL mutation testing for thrombocytosis and myeloproliferative neoplasms, including W515 variants, positive and negative results, VAF, ET, and myelofibrosis.

MPL Mutation Test: Myeloproliferative Neoplasm, Thrombocytosis, and Mutation Meaning

Understand the multiple myeloma test panel, including M protein, SPEP, immunofixation, free light chains, marrow testing, FISH, CRAB criteria, and staging.

Multiple Myeloma Test Panel: M Protein, Free Light Chains, Immunofixation, and...

Understand MYC rearrangement testing in Burkitt and high-grade B-cell lymphoma, including FISH, double-hit MYC/BCL2 disease, BCL6, and double-expressor differences.

MYC Rearrangement Test: Burkitt Lymphoma, Double-Hit Lymphoma, and High-Grade Disease

1...262728...137 Page 27 of 137